MarketsandMarkets-In-Vitro-Diagnostics-Crystal-Ball-Event

Grab before it's gone. Avail 30% Instant Discount

Look what we found for you. Use the code to avail 30% instant discount across all delegate participation opportunities. Get a chance to network with industry leaders and key decision makers. Learn from the best. Grow your knowledge exponentially.

Please fill up the Enquiry Form to reveal the code.

High growth markets which contribute to 20% of your revenues today will contribute 80% in the next 5 years. Identify these new revenue sources at MarketsandMarkets’s Crystal Ball event

The in-vitro diagnostics market is expected to reach USD 96.07 billion by 2025 at a CAGR of 2.6% during the forecast period. The rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, growing awareness regarding diseases diagnosis in developing regions, increasing adoption of fully automated and POC instruments in developed regions, and growing R&D investments by industry players to launch new IVD products are the major factor supporting growth of the in-vitro diagnostics market.

The development of condition-specific markers and tests, growing significance of companion diagnostics, POC tests with multiplexing capabilities are the factors expected to provide significant growth opportunities in the coming years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the composites market, as seen through the lens of eminent CXOs in this space.

What to Expect

Key
Highlights

Most promising opportunities in the in-vitro diagnostics ecosystem, as seen through the lens of eminent CXOs in this space.
Can MS/LC-MS systems gain significant traction in clinical diagnostics in next 5-10 year?

Crystal Ball:
Through the Speakers Perspective

How can liquid biopsy market expand faster in non-oncology indications & out of US & Europe and how can this transition be expedited?
Will laboratories/IVD companies use/expand menu of RT-PCR COVID-19 testing system for other infectious diseases?

Conference Agenda

Top 10 disruptions in In-Vitro Diagnostics Ecosystem

90 minutes of brainstorming among 4 great minds which will aim at bringing out a tangible action plan by discussing the question given below:

What are the top 10 revenue growth opportunities for IVD ecosystem participants over the next 5 years? Which markets, technologies, customer segments are the most attractive to place bets?
Can Point of Care Molecular Diagnostics achieve the penetration level similar to other Point of care technologies (Immunoassay, Clinical Chemistry etc.)?
Can liquid biopsy replace tissue biopsy in next 10-20 years?
How the laboratory developed test industry will evolve in next 5-10 years?
What kind of business models are expected to evolve withing the IVD industry in next 5-10 years?